ISDA

Deposition Date 2014-08-22

Release Date 2014-11-26

Last Version Date 2024-04-03

Entry Detail

PDB ID:

4W7T

Keywords:

CHAPERONE/INHIBITOR

Title:

Crystal Structure of Hsp90-alpha N-domain Bound to the Inhibitor NVP-HSP990

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.80 Å

R-Value Free:

0.21

R-Value Work:

0.17

R-Value Observed:

0.17

Space Group:

I 2 2 2

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Heat shock protein HSP 90-alpha
Gene (Uniprot):HSP90AA1
Chain IDs:A
Chain Length:236
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:P07900 Pfam ID:PF13589 EC:3.6.4.10

Ligand Molecules

3JC

Primary Citation

Design, Structure-Activity Relationship, and in Vivo Characterization of the Development Candidate NVP-HSP990.

McBride, C.M, Levine, B, Xia, Y, Bellamacina, C, Machajewski, T, Gao, Z, Renhowe, P, Antonios-McCrea, W, Barsanti, P, Brinner, K, Costales, A, Doughan, B, Lin, X, Louie, A, McKenna, M, Mendenhall, K, Poon, D, Rico, A, Wang, M, Williams, T.E, Abrams, T, Fong, S, Hendrickson, T, Lei, D, Lin, J, Menezes, D, Pryer, N, Taverna, P, Xu, Y, Zhou, Y, Shafer, C.M.Show

J.Med.Chem. 57 9124 9129 (2014)

PMID: 25368984 DOI: 10.1021/jm501107q

Abstact

Utilizing structure-based drug design, a novel dihydropyridopyrimidinone series which exhibited potent Hsp90 inhibition, good pharmacokinetics upon oral administration, and an excellent pharmacokinetic/pharmacodynamic relationship in vivo was developed from a commercial hit. The exploration of this series led to the selection of NVP-HSP990 as a development candidate.

Legend

Protein

Chemical

Disease

Primary Citation of related structures